【24h】

Altered serum transforming growth factor-beta1 and monocyte chemoattractant protein-1 levels in obstructive jaundice.

机译:梗阻性黄疸患者血清转化生长因子-β1和单核细胞趋化蛋白-1水平改变。

获取原文
获取原文并翻译 | 示例
           

摘要

Impaired immune function has long been documented in patients with obstructive jaundice, and those with jaundice due to extrahepatic biliary obstruction still experience a high rate of postoperative complications and death. Transforming growth factor-beta1 (TGFbeta1) appears to be an important regulator of both normal and pathologic conditions in the liver. Monocyte chemoattractant protein-1 (MCP-1) is an important mediator of monocyte recruitment to inflammatory sites. We hypothesize that obstructive jaundice may alter serum TGFbeta1 and MCP-1 expressions in the rat and that oral bile acid or glutamine (or both) can restore the altered serum TGFbeta1 and MCP-1 expression in rats with obstructive jaundice. Male Sprague-Dawley rats weighing 250 to 300 g were randomized to four groups (n = 10 in each group). Group 1 underwent a sham operation with oral normal saline administration. Group 2 underwent common bile duct ligation (CBDL) with oral normal saline administration. Group 3 underwent CBDL with oral bile acid replacement. Group 4 underwent CBDL with oral glutamine administration. Animals were sacrificed after 3 days (n = 5) and 7 days (n = 5), and blood samples were collected. Serum was obtained after centrifugation for measurement of TGFbeta1 and MCP-1 levels by an enzyme-linked immunosorbent assay. The serum TGFbeta1 level was significantly elevated (p = 0.006) 3 days after CBDL. Oral glutamine administration prevented this elevation, but oral bile acid replacement did not. The serum MCP-1 level showed similar changes. After 3 days of obstructive jaundice, the TGFbeta1 and MCP-1 levels were altered in the rat. Oral glutamine administration, not oral bile acid replacement, was able to prevent these alterations.
机译:阻塞性黄疸患者的免疫功能受损已被长期记录,而由于肝外胆道梗阻而导致黄疸的患者术后并发症和死亡的发生率仍然很高。转化生长因子β1(TGFbeta1)似乎是肝脏正常和病理状况的重要调节剂。单核细胞趋化蛋白-1(MCP-1)是单核细胞募集到炎症部位的重要介质。我们假设梗阻性黄疸可能会改变大鼠血清TGFbeta1和MCP-1的表达,而口服胆汁酸或谷氨酰胺(或两者)可以恢复梗阻性黄疸大鼠血清TGFbeta1和MCP-1的表达。将250至300 g的雄性Sprague-Dawley大鼠随机分为四组(每组n = 10)。第1组接受口服生理盐水的假手术。第2组在口服生理盐水的情况下进行了胆总管结扎术(CBDL)。第3组接受口服胆汁酸替代的CBDL。第4组接受口服谷氨酰胺的CBDL。 3天(n = 5)和7天(n = 5)后处死动物,并收集血样。离心后获得血清,通过酶联免疫吸附测定法测量TGFbeta1和MCP-1水平。 CBDL后3天,血清TGFbeta1水平显着升高(p = 0.006)。口服谷氨酰胺预防了这种升高,但是口服胆汁酸替代却没有。血清MCP-1水平显示相似的变化。在梗阻性黄疸发生3天后,大鼠的TGFbeta1和MCP-1水平发生了改变。口服谷氨酰胺,而不是口服胆汁酸替代,能够预防这些改变。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号